University Hospital Tuebingen: Carcinoma trials

The registry lists 11 Carcinoma studies with University Hospital Tuebingen as lead sponsor. 2 are open to participants now and 1 have results posted.

Phase 1 1Phase 2 1Phase 3 2Phase 4 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• FusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined with Immune Checkpoint InhibitionRecruitingNCT05937295Phase 1
• Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During RadiotherapyRecruitingNCT04517019Not applicable
• Randomized Controlled Trial to Prevent Peritoneal Seeding in Gastric CancerTerminatedNCT01683864Phase 2/3Results posted
• Fingerprint Characterization Tyrosine Kinase Inhibitors in Advanced HCCTerminatedNCT03958669
• Electrochemotherapy for the Inoperable Vulva CarcinomaCompletedNCT03142061Not applicable
• Pilot Study on Intra-abdominal Photodynamic Diagnosis in Peritoneal CarcinosisStatus unknownNCT02840331Phase 3
• Investigation of Desmoplastic Squamous Cell CarcinomaStatus unknownNCT02717936Not applicable
• Hypoxia-based Dose Escalation With Radiochemotherapy in Head and Neck CancerStatus unknownNCT02352792Not applicable
• Recurrence Rate and Esthetic Outcome After Excision of Basal Cell Carcinomas Excluded From Trial NCT00515970Status unknownNCT00639652
• Curettage Versus Excision in Nodular and Superficial Basal Cell CarcinomasSuspendedNCT00515970Not applicable
• Safety and Efficacy Study of Imiquimod 5% Cream Applied 3x Per Week for 8 or 12 Weeks in Low Risk Nodular Basal Cell CarcinomaCompletedNCT00204555Phase 4